{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T04:11:38Z","timestamp":1792469498082,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108193","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T21:13:49Z","timestamp":1633382029000},"page":"108193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"PA","title":["Scutellarein relieves the death and inflammation of tubular epithelial cells in ischemic kidney injury by degradation of COX-2 protein"],"prefix":"10.1016","volume":"101","author":[{"given":"Dong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangle","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9843","key":"10.1016\/j.intimp.2021.108193_b0005","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"S8","key":"10.1016\/j.intimp.2021.108193_b0010","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.21037\/atm.2019.09.156","article-title":"Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal function","volume":"7","author":"Rosiello","year":"2019","journal-title":"Annals of translational med."},{"issue":"5","key":"10.1016\/j.intimp.2021.108193_b0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.intimp.2021.108193_b0020","first-page":"1340","volume":"57","author":"Villacr\u00e9s","year":"2018","journal-title":"Acute Kidney Injury in Children With Acute Respiratory Failure."},{"issue":"11","key":"10.1016\/j.intimp.2021.108193_b0025","first-page":"2199","article-title":"Hypertension in patients with acute kidney injury","volume":"72","author":"Dylewska","year":"2019","journal-title":"Wiadomosci lekarskie (Warsaw, Poland: 1960)"},{"issue":"11","key":"10.1016\/j.intimp.2021.108193_b0030","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrneph.2017.119","article-title":"Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment","volume":"13","author":"Wang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108193_b0035","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review","volume":"18","author":"Petejova","year":"2014","journal-title":"Critical care (London, England)"},{"issue":"1","key":"10.1016\/j.intimp.2021.108193_b0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bpa.2019.12.002","article-title":"Acute kidney injury: A critical care perspective for orthotopic liver transplantation","volume":"34","author":"MacDonald","year":"2020","journal-title":"Best practice & res. Clinical anaesthesiol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108193_b0045","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/sj.ki.5000216","article-title":"Risk factors of acute renal failure after liver transplantation","volume":"69","author":"Cabezuelo","year":"2006","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.intimp.2021.108193_b0050","doi-asserted-by":"crossref","first-page":"F1169","DOI":"10.1152\/ajprenal.00654.2012","article-title":"Relaxin protects against renal ischemia-reperfusion injury","volume":"305","author":"Yoshida","year":"2013","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.intimp.2021.108193_b0055","unstructured":"!!! INVALID CITATION !!!."},{"issue":"3","key":"10.1016\/j.intimp.2021.108193_b0060","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3892\/or.2020.7677","article-title":"Comparative proteomic analysis uncovers potential biomarkers involved in the anticancer effect of Scutellarein in human gastric cancer cells","volume":"44","author":"Saralamma","year":"2020","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.108193_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3892\/ijmm.2014.1997","article-title":"Scutellarein inhibits cancer cell metastasis in vitro and attenuates the development of fibrosarcoma in vivo","volume":"35","author":"Shi","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2021.108193_b0070","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.18240\/ijo.2020.10.05","article-title":"Scutellarein alleviates the dysfunction of inner blood-retinal-barrier initiated by hyperglycemia-stimulated microglia cells","volume":"13","author":"Li","year":"2020","journal-title":"Int. j. ophthalmol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108193_b0075","first-page":"5581","article-title":"Scutellarein suppresses A\u03b2-induced memory impairment via inhibition of the NF-\u03baB pathway in vivo and in vitro","volume":"17","author":"Huang","year":"2019","journal-title":"Oncol. letters"},{"issue":"7","key":"10.1016\/j.intimp.2021.108193_b0080","first-page":"11951","volume":"234","author":"Fu","year":"2019","journal-title":"Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivo."},{"issue":"19","key":"10.1016\/j.intimp.2021.108193_b0085","doi-asserted-by":"crossref","first-page":"126608","DOI":"10.1016\/j.bmcl.2019.08.012","article-title":"Hybrid molecules of scutellarein and tertramethylpyrazine's active metabolites for ischemic stroke","volume":"29","author":"Dong","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2021.108193_b0090","doi-asserted-by":"crossref","first-page":"10667","DOI":"10.3390\/molecules170910667","article-title":"Synthesis and protective effect of scutellarein on focal cerebral ischemia\/reperfusion in rats","volume":"17","author":"Qian","year":"2012","journal-title":"Mol. (Basel, Switzerland)"},{"issue":"11","key":"10.1016\/j.intimp.2021.108193_b0095","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms12118208","article-title":"Synthesis and bio-activity evaluation of scutellarein as a potent agent for the therapy of ischemic cerebrovascular disease","volume":"12","author":"Qian","year":"2011","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.108193_b0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0008-6363(02)00414-5","article-title":"Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia\/reperfusion injury and mediates the late phase of preconditioning","volume":"55","author":"Bolli","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2021.108193_b0105","first-page":"1","article-title":"COX-2 Inhibitors and Gastric Cancer","volume":"2014","author":"Wang","year":"2014","journal-title":"Gastroenterol. res. practice"},{"issue":"3-4","key":"10.1016\/j.intimp.2021.108193_b0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.prostaglandins.2011.11.004","article-title":"Cyclooxygenase-2 and kidney failure","volume":"98","author":"Rios","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"6","key":"10.1016\/j.intimp.2021.108193_b0115","doi-asserted-by":"crossref","first-page":"F1898","DOI":"10.1152\/ajprenal.00360.2007","article-title":"Developmental regulation of calcineurin isoforms in the rodent kidney: association with COX-2","volume":"293","author":"Liu","year":"2007","journal-title":"Am. J. physiol. Renal physiol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108193_b0120","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ki.2012.423","article-title":"Netrin-1 regulates the inflammatory response of neutrophils and macrophages, and suppresses ischemic acute kidney injury by inhibiting COX-2-mediated PGE2 production","volume":"83","author":"Ranganathan","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2021.108193_b0125","doi-asserted-by":"crossref","first-page":"155574","DOI":"10.1016\/j.cyto.2021.155574","article-title":"Thalidomide reduces glycerol-induced acute kidney injury by inhibition of NF-\u03baB, NLRP3 inflammasome, COX-2 and inflammatory cytokines","volume":"144","author":"Amirshahrokhi","year":"2021","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.intimp.2021.108193_b0130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ki.2011.450","article-title":"Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia\/reperfusion injury","volume":"81","author":"Linkermann","year":"2012","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.intimp.2021.108193_b0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided. Mol. Des."},{"issue":"4","key":"10.1016\/j.intimp.2021.108193_b0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/mi.6.4.6","article-title":"COX-2 in inflammation and resolution","volume":"6","author":"Rajakariar","year":"2006","journal-title":"Mol. Interventions"},{"issue":"1","key":"10.1016\/j.intimp.2021.108193_b0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev-biochem-061516-044908","article-title":"Proteasomal and Autophagic Degradation Systems","volume":"86","author":"Dikic","year":"2017","journal-title":"Annu. Rev. Biochem."},{"issue":"20","key":"10.1016\/j.intimp.2021.108193_b0150","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1080\/15384101.2020.1814044","article-title":"Methionine represses the autophagy of gastric cancer stem cells via promoting the methylation and phosphorylation of RAB37","volume":"19","author":"Xin","year":"2020","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"4","key":"10.1016\/j.intimp.2021.108193_b0155","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1007\/s11033-019-04853-0","article-title":"Luteolin confers renoprotection against ischemia-reperfusion injury via involving Nrf2 pathway and regulating miR320","volume":"46","author":"Kalbolandi","year":"2019","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.108193_b0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/0886022X.2018.1497517","article-title":"Effect of apigenin on apoptosis induced by renal ischemia\/reperfusion injury in vivo and in vitro","volume":"40","author":"Wang","year":"2018","journal-title":"Ren. Fail."},{"issue":"2","key":"10.1016\/j.intimp.2021.108193_b0165","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1046\/j.1523-1755.2003.00774.x","article-title":"Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation in Euro-Collins and University of Wisconsin solutions","volume":"63","author":"Ahlenstiel","year":"2003","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.intimp.2021.108193_b0170","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1523-1755.2004.761_2.x","article-title":"Ischemic acute renal failure: an inflammatory disease?","volume":"66","author":"Bonventre","year":"2004","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.intimp.2021.108193_b0175","doi-asserted-by":"crossref","first-page":"F887","DOI":"10.1152\/ajprenal.00050.2001","article-title":"Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function","volume":"281","author":"Basile","year":"2001","journal-title":"Am. J. physiol. Renal physiol."},{"key":"10.1016\/j.intimp.2021.108193_b0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pbb.2014.01.003","article-title":"Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats","volume":"118","author":"Tang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.intimp.2021.108193_b0185","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.2040-4603.2012.tb00431.x","article-title":"Pathophysiology of acute kidney injury","volume":"2","author":"Basile","year":"2012","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/j.intimp.2021.108193_b0190","doi-asserted-by":"crossref","unstructured":"Liu Y, Wang J, Zhang X, Wang L, Hao T, Cheng Y: Scutellarin Exerts Hypoglycemic and Renal Protective Effects in db\/db Mice via the Nrf2\/HO-1 Signaling Pathway. 2019, 2019:1354345.","DOI":"10.1155\/2019\/1354345"},{"key":"10.1016\/j.intimp.2021.108193_b0195","doi-asserted-by":"crossref","first-page":"108647","DOI":"10.1016\/j.biopha.2019.108647","article-title":"Renoprotective effect of scutellarin on cisplatin-induced renal injury in mice: Impact on inflammation, apoptosis, and autophagy","volume":"112","author":"Sun","year":"2019","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2021.108193_b0200","article-title":"Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2021.108193_b0205","doi-asserted-by":"crossref","first-page":"F1113","DOI":"10.1152\/ajprenal.00430.2015","article-title":"COX-2 gene dosage-dependent defects in kidney development","volume":"310","author":"Slattery","year":"2016","journal-title":"Am. J. physiol. Renal physiol."},{"issue":"17","key":"10.1016\/j.intimp.2021.108193_b0210","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2174\/1381612003398717","article-title":"COX-2 and the kidneys","volume":"6","author":"Stichtenoth","year":"2000","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.intimp.2021.108193_b0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1100\/tsw.2006.122","article-title":"COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation","volume":"6","author":"Wallace","year":"2006","journal-title":"Sci. World J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921008298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:39:02Z","timestamp":1761586742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921008298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"alternative-id":["S1567576921008298"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108193","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scutellarein relieves the death and inflammation of tubular epithelial cells in ischemic kidney injury by degradation of COX-2 protein","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108193"}}